| Promedica Skilled Nrsg And Rehab (lancaster) | |
| 100 Abbeyville Road, Lancaster, Pennsylvania 17603 | |
| (717) 397-4261 | |
| Name | Promedica Skilled Nrsg And Rehab (lancaster) |
|---|---|
| Location | 100 Abbeyville Road, Lancaster, Pennsylvania |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 172 |
| Occupancy Rate | 69.48% |
| Medicare ID (CCN) | 395199 |
| Legal Business Name | Manor Care Of Lancaster Pa Llc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1467162172 |
| Organization Name | 100 ABBEYVILLE ROAD OPERATIONS LLC |
| Doing Business As | ABBEYVILLE SKILLED NURSING AND REHABILITATION CENTER |
| Address | 100 Abbeyville Rd, Lancaster, PA 17603 |
| Phone Number | 610-444-6350 |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Leicester geneticists have discovered a potential defence against Huntington's disease - a fatal neurodegenerative disorder which currently has no cure.
Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.
Today, the U.S. Food and Drug Administration issued the first marketing denial orders (MDOs) for electronic nicotine delivery system (ENDS) products after determining the applications for about 55,000 flavored ENDS products from three applicants lacked sufficient evidence that they have a benefit to adult smokers sufficient to overcome the public health threat posed by the well-documented, alarming levels of youth use of such products.
› Verified 9 days ago
| NPI Number | 1518913136 |
| Organization Name | MANOR CARE OF LANCASTER PA, LLC |
| Doing Business As | PROMEDICA SKILLED NURSING AND REHABILITATION (LANCASTER) |
| Address | 100 Abbeyville Rd, Lancaster, PA 17603 |
| Phone Number | 717-397-4261 |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Leicester geneticists have discovered a potential defence against Huntington's disease - a fatal neurodegenerative disorder which currently has no cure.
Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.
Today, the U.S. Food and Drug Administration issued the first marketing denial orders (MDOs) for electronic nicotine delivery system (ENDS) products after determining the applications for about 55,000 flavored ENDS products from three applicants lacked sufficient evidence that they have a benefit to adult smokers sufficient to overcome the public health threat posed by the well-documented, alarming levels of youth use of such products.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Leicester geneticists have discovered a potential defence against Huntington's disease - a fatal neurodegenerative disorder which currently has no cure.
Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.
Today, the U.S. Food and Drug Administration issued the first marketing denial orders (MDOs) for electronic nicotine delivery system (ENDS) products after determining the applications for about 55,000 flavored ENDS products from three applicants lacked sufficient evidence that they have a benefit to adult smokers sufficient to overcome the public health threat posed by the well-documented, alarming levels of youth use of such products.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 23.58 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.99 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 36.07 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.98 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.42 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.76 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.31 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 92.43 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 20.57 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 75.26 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.47 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 43.12 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.86 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 3.19 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94.41 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 65.12 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 79.26 | 82.93 |
News Archive
Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.
Leicester geneticists have discovered a potential defence against Huntington's disease - a fatal neurodegenerative disorder which currently has no cure.
Philip Morris International has announced the signing of a 12-year agreement with the European Commission and 10 member states of the European Union to work together to combat the illegal trade in cigarettes worldwide.
Today, the U.S. Food and Drug Administration issued the first marketing denial orders (MDOs) for electronic nicotine delivery system (ENDS) products after determining the applications for about 55,000 flavored ENDS products from three applicants lacked sufficient evidence that they have a benefit to adult smokers sufficient to overcome the public health threat posed by the well-documented, alarming levels of youth use of such products.
› Verified 9 days ago
Rose City Nursing And Rehab At Lancaster Location: 425 North Duke Street, Lancaster, Pennsylvania 17602 Phone: (717) 397-4281 | |
Promedica Skilled Nrsg And Rehab (lancaster) Location: 100 Abbeyville Road, Lancaster, Pennsylvania 17603 Phone: (717) 397-4261 | |
Hamilton Arms Center Location: 336 South West End Avenue, Lancaster, Pennsylvania 17603 Phone: (717) 393-0419 | |
Calvary Fellowship Homes Inc Location: 502 Elizabeth Drive, Lancaster, Pennsylvania 17601 Phone: (717) 393-0711 |